finanzen.net
13.03.2019 17:28
Bewerten
(0)

Health Canada finalizes regulations to provide public access to clinical information on drugs and medical devices

DRUCKEN

OTTAWA, March 13, 2019 /CNW/ - Canadians want greater access to credible information that will enable them to make well-informed decisions about their health and that of their families. Health Canada recognizes that increasing access to clinical data on drugs and medical devices can have widespread benefits throughout the health care system and on the health outcomes of Canadians.

On March 20, 2019, Health Canada will publish final regulations that allow for the public release of clinical information on drugs and medical devices. Clinical information is the data that companies provide when requesting authorization of these products, and includes study reports and clinical trial results. These regulations are one of key transparency measures introduced under Vanessa's Law.

Clinical information will be made available to Canadians through Health Canada's new Clinical Information Portal as of March 13, 2019. At launch, the portal will include clinical information on a small number of products, provided by volunteer companies in advance of the final regulations.

Following the coming into force of the regulations, Health Canada will post clinical information from drug submissions as the Department completes its review of each submission. Proactive disclosure for medical devices will start in 2021, to coincide with steps the European Union is taking to increase the transparency of clinical information for medical devices, and to reduce the burden on stakeholders by aligning approaches. Health Canada will also make information about drugs and medical devices already on the market available upon request, and add this information to the portal. Health Canada consulted extensively with academic researchers, health care professionals, patient groups and industry on this approach to determine what information should be shared and in what form. 

As part of its Action Plan on Medical Devices launched in December 2018, Health Canada committed to providing more information to Canadians on medical devices. These regulations represent one key component of that plan.

Quotes

"The clinical information in drug and medical device submissions is a tremendous resource that researchers can tap into and use to benefit the health and safety of Canadians. I look forward to the new insights that will come from this rich source of open data."

The Honourable Ginette Petitpas Taylor
Minister of Health

Quick Facts

  • The Health Canada Clinical Information Portal is an online tool to access clinical information about drugs and medical devices. It will allow site visitors to search for published material using key product identifiers and to request unpublished material.
  • Health Canada will consult manufacturers to ensure that confidential and personal information is removed before the Department releases any information.
  • Health Canada aims to release information about drugs within 120 days of completing the review of a drug submission.

Associated Links

Public Release of Clinical Information Guidance Document   
Public Release of Clinical Information Canada Gazette, Part I   
Request a copy of the regulations (Note: The regulations will be published in Canada Gazette, Part II, on March 20, 2019.)
Canada Gazette publications
Health Canada's Action Plan on Medical Devices
Report a Health and Safety Concern
New Safety and Effectiveness Reviews
The Drug and Health Product Register
MedEffect Canada
Summary safety reviews
Drug product database

 

SOURCE Health Canada

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX geht fester ins Oster-Wochenende -- Gewinnmitnahmen bei Wirecard-Aktie -- Pinterest-Aktie mit fulminantem Börsendebüt -- Daimler, Senvion, Deutsche Post, OSRAM, Zoom-IPO im Fokus

Apple nimmt zweite Roboter-Linie zum iPhone-Recycling in Betrieb. PUMA-Aktionäre segnen Aktiensplit ab. Samsung nimmt Falt-Handy wegen möglicher Mängel unter die Lupe. 3,4 Milliarden Dollar: Cannabis-Megadeal in Nordamerika eingefädelt. Nestlé: Robuster Start ins neue Geschäftsjahr. US-Versicherer Travelers steigert Gewinn.

Die 5 beliebtesten Top-Rankings

Die beliebtesten Arbeitgeber in Deutschland
Hier gibt es die beliebtesten Jobs
Die zehn größten Kapitalvernichter
Hier wurde am meisten Anlegergeld verbrannt
DIe innovativsten Unternehmen
Diese Unternehmen sind am fortschrittlichsten
Das hat sich geändert
Diese Aktien hat George Soros im Depot
Diese Aktien hat Warren Buffett im Depot
Einige Änderungen unter den Top-Positionen
mehr Top Rankings

Umfrage

Wirtschaftsminister Peter Altmaier (CDU) sieht sich derzeit starker Kritik ausgesetzt. Zu Recht?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Deutsche Bank AG514000
Daimler AG710000
Wirecard AG747206
Scout24 AGA12DM8
Apple Inc.865985
Amazon906866
Allianz840400
AMD (Advanced Micro Devices) Inc.863186
BMW AG519000
TeslaA1CX3T
E.ON SEENAG99
CommerzbankCBK100
BASFBASF11
BayerBAY001
adidasA1EWWW